Cargando…

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

OBJECTIVE: To obtain real-world data on outcomes of belimumab treatment and respective prognostic factors in patients with systemic lupus erythematosus (SLE). METHODS: Observational study of 188 active SLE patients (median disease duration 6.2 years, two previous immunosuppressive/biological agents)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikoloudaki, Myrto, Nikolopoulos, Dionysis, Koutsoviti, Sofia, Flouri, Irini, Kapsala, Noemin, Repa, Argyro, Katsimbri, Pelagia, Theotikos, Evangelos, Pitsigavdaki, Sofia, Pateromichelaki, Katerina, Bertsias, Antonios, Elezoglou, Antonia, Sidiropoulos, Prodromos, Fanouriakis, Antonis, Boumpas, Dimitrios, Bertsias, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845912/ https://www.ncbi.nlm.nih.gov/pubmed/36685524 http://dx.doi.org/10.3389/fimmu.2022.1074044

Ejemplares similares

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2020)

Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
por: Bertsias, Antonios, et al.
Publicado: (2022)

Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2018)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
por: Nikolopoulos, Dionysis S, et al.
Publicado: (2020)

Spontaneous Chalk-Stick Fracture in Ankylosing Spondylitis: A Case Report
por: Katsimpari, Chaido, et al.
Publicado: (2022)

Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
por: Choulaki, Christianna, et al.
Publicado: (2015)

Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis
por: Repa, Argyro, et al.
Publicado: (2019)

The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital
por: Kougkas, Nikolaos, et al.
Publicado: (2019)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
por: Nikolopoulos, Dionysis, et al.
Publicado: (2022)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
por: Antypa, Despina, et al.
Publicado: (2021)

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
por: Panousis, Nikolaos I, et al.
Publicado: (2019)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023)

Familial Mediterranean Fever Mimicking Whipple’s Disease: A Case Report and Review of the Literature
por: Flouda, Sofia, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
por: Emmanouilidou, Evgenia, et al.
Publicado: (2023)

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
por: Kostopoulou, Myrto, et al.
Publicado: (2020)

Septic Arthritis Complicating a Gout Flare: Report of Two Cases and Review of the Literature
por: Tzanis, Prokopios, et al.
Publicado: (2022)

Pulmonary fibrosis and microscopic polyangiitis in a 75-year-old woman
por: Koutsoviti, Sofia, et al.
Publicado: (2019)

Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
por: Nikolopoulos, Dionysis, et al.
Publicado: (2019)

Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood
por: Papanikolaou, Sofia, et al.
Publicado: (2022)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
por: Gergianaki, Irini, et al.
Publicado: (2021)

Baseline IgG-Fc N-glycosylation profile is associated with long-term outcome in a cohort of early inflammatory arthritis patients
por: Sénard, Thomas, et al.
Publicado: (2022)

Periaortitis and diffuse subendocardial vasculitis in a patient with systemic lupus erythematosus – Lupus flare or a coexisting disease?
por: Gioti, Ourania, et al.
Publicado: (2019)

Changing paradigms in the treatment of systemic lupus erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
por: Neupane, Binod, et al.
Publicado: (2023)

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
por: Stagakis, Ilias, et al.
Publicado: (2012)

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion
por: Gkirtzimanaki, Katerina, et al.
Publicado: (2018)

Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis
por: Pentari, Anastasia, et al.
Publicado: (2023)

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
por: Nakou, Magda, et al.
Publicado: (2009)

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022)

Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis
por: Frangou, Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iq222pceeo3n72j5c61660b4m3